Related Experiment Video

Updated: Mar 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.4K

Diabetes Update: Primary Care of Patients With Type 1 Diabetes

Beth Choby1

  • 1University of Tennessee Health Science Center Department of Medical Education, 920 Madison Building 7th floor, Memphis, TN 3816-30000.

FP Essentials
|May 23, 2017
PubMed

Insights

Type 1 diabetes (T1D) incidence is rising across all races in the US, affecting children acutely and adults gradually. Effective T1D management requires tailored care plans and new therapies.

Area of Science:

  • Endocrinology and Metabolism
  • Autoimmune Diseases
  • Pediatric Endocrinology

Background:

  • Type 1 diabetes (T1D) incidence and prevalence are increasing in diverse populations within the United States.
  • T1D presents with acute symptoms in children and gradual symptoms in adults, sometimes mimicking type 2 diabetes (T2D).
  • Conditions like Latent Autoimmune Diabetes in Adults (LADA) and Maturity-Onset Diabetes of the Young (MODY) can be misdiagnosed as T1D.

Purpose of the Study:

  • To review the current landscape of type 1 diabetes management.
  • To highlight challenges in T1D diagnosis and treatment.
  • To emphasize the importance of personalized care in T1D.

Main Methods:

  • Literature review of recent advancements in T1D management.
  • Analysis of diagnostic challenges and differential diagnoses for T1D.
  • Discussion of emerging therapeutic strategies for T1D and T2D.

Main Results:

  • Increasing T1D rates necessitate improved screening and management strategies.
  • Advanced monitoring and insulin delivery systems offer greater flexibility for T1D patients.
  • Noninsulin therapies are under investigation for both T1D and T2D.

Conclusions:

  • Personalized care plans tailored to developmental age are crucial for effective T1D management.
  • Early and accurate diagnosis is essential to prevent common T1D complications.
  • Ongoing research into novel therapies promises improved outcomes for individuals with T1D.

More Related Videos

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.5K
Isolation of Human Islets from Partially Pancreatectomized Patients11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

17.0K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
957